Health In Tech, Inc.

Name: Health In Tech, Inc. standardized financial statements, quarterly
Creator: Listed

HITNasdaqCIK 2019505FinancialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$8.1m, Q2 FY2026

Net income−$2.5m, Q2 FY2026

Health In Tech, Inc., income statement, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	5,125	5,002	4,459	4,905	8,015	9,314	8,490	7,509	8,772	8,057
Cost of revenue	$k	990	975	980	1,107	2,660	3,004	3,346	3,380	4,262	4,134
Gross profit	$k	4,135	4,028	3,479	3,797	5,355	6,310	5,144	4,129	4,509	3,922
Research and development	$k	760	702	718	634	538	583	236	213	920	876
Interest expense	$k	165	165	165	0.0	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$k	91.2	63.3	30.7	33.4	186	203	148	(141)	(480)	(810)
Net income	$k	101	338	376	(144)	499	631	452	(303)	(1,588)	(2,511)
Diluted EPS	$ per share	not reported	0.01	0.01	not reported	0.01	0.01	0.01	not reported	(0.03)	(0.04)
Basic EPS	$ per share	not reported	0.01	0.01	not reported	0.01	0.01	0.01	not reported	(0.03)	(0.04)

Balance sheet

Cash and equivalents$6.5m, Q2 FY2026

Shareholders' equity$19.6m, Q2 FY2026

Health In Tech, Inc., balance sheet, quarterly
Line item	Unit	period not labelled2022-12-31	period not labelled2023-12-31	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	not reported	2.4	not reported	not reported	not reported	7.8	7.6	8.1	8.0	7.7	10.3	6.5
Current assets	$m	not reported	6.9	not reported	not reported	not reported	10.8	15.6	14.9	15.0	16.2	22.1	21.8
Total assets	$m	not reported	11.5	not reported	not reported	not reported	15.8	21.3	22.2	22.8	23.1	29.0	29.6
Current liabilities	$m	not reported	4.8	not reported	not reported	not reported	2.1	6.8	5.4	5.2	5.2	7.0	10.0
Total liabilities	$m	not reported	5.4	not reported	not reported	not reported	2.6	7.2	5.8	5.6	6.0	7.4	10.0
Shareholders' equity	$m	1.4	6.1	6.2	6.5	6.9	13.2	14.2	16.4	17.2	17.1	21.6	19.6

Cash flow

Operating cash flow−$2.9m, Q2 FY2026

Health In Tech, Inc., cash flow, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(680)	1,267	2,121	(531)	527	1,481	674	451	(3,319)	(2,912)

Diluted shares (weighted)62.83m, Q2 FY2026

Health In Tech, Inc., shares, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	51.8	51.8	51.8	57.0	55.6	58.8	57.4	62.8

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.

Health In Tech, Inc.

Income statement

Balance sheet

Cash flow

Shares